Evidence map›Paper›PMID 19666223›Full record

ArticleBioorganic & medicinal chemistry letters2009

Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials.

Brian T Grimberg, Maria M Jaworska, Lindsay B Hough, Peter A Zimmerman, James G Phillips

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Expanding the Antimalarial Drug Arsenal-Now, But How?Pharmaceuticals (Basel, Switzerland) · 2011
    Article
  8. Article
  9. Review
  10. An adaptable two-color flow cytometric assay to quantitate the invasion of erythrocytes by Plasmodium falciparum parasites.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2010
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brian T GrimbergCenter for Global Health & Diseases, Case Western Reserve University, Cleveland, OH 44106-7286, USA.
Maria M Jaworska
Lindsay B Hough
Peter A Zimmerman
James G Phillips

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Drew James Adams · 1987 to 2026
$142.3M
HISTAMINERGIC MECHANISMS OF NON-OPIATE ANALGESIAR01DA003816 · NIDA · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI HOUGH, LINDSAY · 1986 to 2009
$2.8M
Chloroquine Resistance and pfcrt Variants in PNGR01AI052312 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER A. · 2002 to 2006
$2.7M
NCI NIH HHS P30 CA043703NIAID NIH HHS AI52312NIAID NIH HHS R01 AI052312NIDA NIH HHS DA-03816NIDA NIH HHS R01 DA003816
6 · The paper itself

Abstract

A new flow cytometry method that uses an optimized DNA and RNA staining strategy to monitor the growth and development of the Plasmodium falciparum strain W2mef has been used in a pilot study and has identified Bay 43-9006 1, SU 11274 2, and TMC 125 5 as compounds that exhibit potent (<1 microM) overall and ring stage in vitro antimalarial activity.

Indexed as

AnimalsAntimalarialsDNA, ProtozoanDrug DiscoveryDrug ResistanceErythrocytesFlow CytometryMalaria, FalciparumParasitic Sensitivity TestsPlasmodium falciparumRNA, ProtozoanStructure-Activity RelationshipAntimalarialsDNA, ProtozoanRNA, Protozoan

Identifiers

PMID19666223
PMCPMC3131497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.